Yin Chang-jun
Papers
1
Total Citations
22
H-Index
1
About
Dr. Yin Chang-jun has made significant contributions to the surgical and interventional management of kidney cancer, with a particular focus on small renal masses (SRMs). His research centers on comparing the efficacy and safety of minimally invasive treatments, such as radiofrequency ablation (RFA), against traditional surgical approaches like partial nephrectomy. His most cited work, a 2014 systematic review and meta-analysis, critically evaluated these two modalities for clinical stage 1 renal tumors, providing pivotal evidence that has helped guide clinical decision-making in an era of shifting treatment paradigms. This study, cited 22 times, underscores his role in advancing evidence-based urologic oncology. Dr. Yin’s work addresses the rising incidence of SRMs and the growing need for nephron-sparing strategies, directly impacting how clinicians balance oncologic control with renal function preservation. His research is essential reading for urologists and oncologists seeking to optimize outcomes for patients with early-stage kidney cancer.
Research Focus
Key Achievements
Top Papers
- 1